Orr-Urtreger A - Search Results

1

Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene.

Mirelman A, Alcalay RN, Saunders-Pullman R, Yasinovsky K, Thaler A, Gurevich T, Mejia-Santana H, Raymond D, Gana-Weisz M, Bar-Shira A, Ozelius L, Clark L, Orr-Urtreger A, Bressman S, Marder K, Giladi N; LRRK2 AJ consortium. Mirelman A, et al. Mov Disord. 2015 Jun;30(7):981-6. doi: 10.1002/mds.26213. Epub 2015 Mar 21. Mov Disord. 2015. PMID: 25809001 Free PMC article.

2

A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews.

Rennert H, Bercovich D, Hubert A, Abeliovich D, Rozovsky U, Bar-Shira A, Soloviov S, Schreiber L, Matzkin H, Rennert G, Kadouri L, Peretz T, Yaron Y, Orr-Urtreger A. Rennert H, et al. Am J Hum Genet. 2002 Oct;71(4):981-4. doi: 10.1086/342775. Epub 2002 Jul 23. Am J Hum Genet. 2002. PMID: 12145743 Free PMC article.

3

Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft.

Bar-Shira A, Pinthus JH, Rozovsky U, Goldstein M, Sellers WR, Yaron Y, Eshhar Z, Orr-Urtreger A. Bar-Shira A, et al. Cancer Res. 2002 Dec 1;62(23):6803-7. Cancer Res. 2002. PMID: 12460888

4

Combined cytogenetic and array-based comparative genomic hybridization analyses of Wilms tumors: amplification and overexpression of the multidrug resistance associated protein 1 gene (MRP1) in a metachronous tumor.

Goldstein M, Rennert H, Bar-Shira A, Burstein Y, Yaron Y, Orr-Urtreger A. Goldstein M, et al. Cancer Genet Cytogenet. 2003 Mar;141(2):120-7. doi: 10.1016/s0165-4608(02)00667-2. Cancer Genet Cytogenet. 2003. PMID: 12606129

5

RNASEL mutation screening and association study in Ashkenazi and non-Ashkenazi prostate cancer patients.

Orr-Urtreger A, Bar-Shira A, Bercovich D, Matarasso N, Rozovsky U, Rosner S, Soloviov S, Rennert G, Kadouri L, Hubert A, Rennert H, Matzkin H. Orr-Urtreger A, et al. Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):474-9. doi: 10.1158/1055-9965.EPI-05-0606. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16537704

6

Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6.

Bar-Shira A, Matarasso N, Rosner S, Bercovich D, Matzkin H, Orr-Urtreger A. Bar-Shira A, et al. Prostate. 2006 Jul 1;66(10):1052-60. doi: 10.1002/pros.20425. Prostate. 2006. PMID: 16598737

7

Array-based comparative genome hybridization in clinical genetics.

Bar-Shira A, Rosner G, Rosner S, Goldstein M, Orr-Urtreger A. Bar-Shira A, et al. Pediatr Res. 2006 Sep;60(3):353-8. doi: 10.1203/01.pdr.0000233012.00447.68. Epub 2006 Jul 20. Pediatr Res. 2006. PMID: 16857771

8

The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer.

Orr-Urtreger A, Bar-Shira A, Matzkin H, Mabjeesh NJ. Orr-Urtreger A, et al. Prostate. 2007 Jan 1;67(1):8-13. doi: 10.1002/pros.20433. Prostate. 2007. PMID: 16998808

9

Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate.

Matarasso N, Bar-Shira A, Rozovski U, Rosner S, Orr-Urtreger A. Matarasso N, et al. Neoplasia. 2007 Sep;9(9):707-15. doi: 10.1593/neo.07322. Neoplasia. 2007. PMID: 17898866 Free PMC article.

10

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N. Orr-Urtreger A, et al. Neurology. 2007 Oct 16;69(16):1595-602. doi: 10.1212/01.wnl.0000277637.33328.d8. Neurology. 2007. PMID: 17938369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters